BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38726868)

  • 1. AcrIIA28 is a metalloprotein that specifically inhibits targeted-DNA loading to SpyCas9 by binding to the REC3 domain.
    Kim GE; Park HH
    Nucleic Acids Res; 2024 Jun; 52(11):6459-6471. PubMed ID: 38726868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phage AcrIIA2 DNA Mimicry: Structural Basis of the CRISPR and Anti-CRISPR Arms Race.
    Liu L; Yin M; Wang M; Wang Y
    Mol Cell; 2019 Feb; 73(3):611-620.e3. PubMed ID: 30606466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad-spectrum anti-CRISPR proteins facilitate horizontal gene transfer.
    Mahendra C; Christie KA; Osuna BA; Pinilla-Redondo R; Kleinstiver BP; Bondy-Denomy J
    Nat Microbiol; 2020 Apr; 5(4):620-629. PubMed ID: 32218510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of CRISPR-SpyCas9 inhibition by an anti-CRISPR protein.
    Dong D; Guo M; Wang S; Zhu Y; Wang S; Xiong Z; Yang J; Xu Z; Huang Z
    Nature; 2017 Jun; 546(7658):436-439. PubMed ID: 28448066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of potent and versatile CRISPR-Cas9 inhibitors engineered for chemically controllable genome editing.
    Song G; Zhang F; Tian C; Gao X; Zhu X; Fan D; Tian Y
    Nucleic Acids Res; 2022 Mar; 50(5):2836-2853. PubMed ID: 35188577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An anti-CRISPR from a virulent streptococcal phage inhibits Streptococcus pyogenes Cas9.
    Hynes AP; Rousseau GM; Lemay ML; Horvath P; Romero DA; Fremaux C; Moineau S
    Nat Microbiol; 2017 Oct; 2(10):1374-1380. PubMed ID: 28785032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution structure and dynamics of anti-CRISPR AcrIIA4, the Cas9 inhibitor.
    Kim I; Jeong M; Ka D; Han M; Kim NK; Bae E; Suh JY
    Sci Rep; 2018 Mar; 8(1):3883. PubMed ID: 29497118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR Proteins.
    Lee J; Mir A; Edraki A; Garcia B; Amrani N; Lou HE; Gainetdinov I; Pawluk A; Ibraheim R; Gao XD; Liu P; Davidson AR; Maxwell KL; Sontheimer EJ
    mBio; 2018 Dec; 9(6):. PubMed ID: 30514786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas Systems in Streptococci.
    Gong T; Lu M; Zhou X; Zhang A; Tang B; Chen J; Jing M; Li Y
    Curr Issues Mol Biol; 2019; 32():1-38. PubMed ID: 31166168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition Mechanism of an Anti-CRISPR Suppressor AcrIIA4 Targeting SpyCas9.
    Yang H; Patel DJ
    Mol Cell; 2017 Jul; 67(1):117-127.e5. PubMed ID: 28602637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temperature-Responsive Competitive Inhibition of CRISPR-Cas9.
    Jiang F; Liu JJ; Osuna BA; Xu M; Berry JD; Rauch BJ; Nogales E; Bondy-Denomy J; Doudna JA
    Mol Cell; 2019 Feb; 73(3):601-610.e5. PubMed ID: 30595438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coordinated Actions of Cas9 HNH and RuvC Nuclease Domains Are Regulated by the Bridge Helix and the Target DNA Sequence.
    Babu K; Kathiresan V; Kumari P; Newsom S; Parameshwaran HP; Chen X; Liu J; Qin PZ; Rajan R
    Biochemistry; 2021 Dec; 60(49):3783-3800. PubMed ID: 34757726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The initiation, propagation and dynamics of CRISPR-SpyCas9 R-loop complex.
    Zeng Y; Cui Y; Zhang Y; Zhang Y; Liang M; Chen H; Lan J; Song G; Lou J
    Nucleic Acids Res; 2018 Jan; 46(1):350-361. PubMed ID: 29145633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cas9 Allosteric Inhibition by the Anti-CRISPR Protein AcrIIA6.
    Fuchsbauer O; Swuec P; Zimberger C; Amigues B; Levesque S; Agudelo D; Duringer A; Chaves-Sanjuan A; Spinelli S; Rousseau GM; Velimirovic M; Bolognesi M; Roussel A; Cambillau C; Moineau S; Doyon Y; Goulet A
    Mol Cell; 2019 Dec; 76(6):922-937.e7. PubMed ID: 31604602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a Type II-A CRISPR-Cas System in
    Mosterd C; Moineau S
    mSphere; 2020 Jun; 5(3):. PubMed ID: 32581075
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-CRISPR proteins targeting the CRISPR-Cas system enrich the toolkit for genetic engineering.
    Liu Q; Zhang H; Huang X
    FEBS J; 2020 Feb; 287(4):626-644. PubMed ID: 31730297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of the anti-CRISPR, AcrIIC4.
    Kim GE; Lee SY; Park HH
    Protein Sci; 2021 Dec; 30(12):2474-2481. PubMed ID: 34676610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AcrIIA5 Inhibits a Broad Range of Cas9 Orthologs by Preventing DNA Target Cleavage.
    Song G; Zhang F; Zhang X; Gao X; Zhu X; Fan D; Tian Y
    Cell Rep; 2019 Nov; 29(9):2579-2589.e4. PubMed ID: 31775029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent CRISPR-Cas9 inhibitors from
    Watters KE; Shivram H; Fellmann C; Lew RJ; McMahon B; Doudna JA
    Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6531-6539. PubMed ID: 32156733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CRISPRs: Protein Inhibitors of CRISPR-Cas Systems.
    Davidson AR; Lu WT; Stanley SY; Wang J; Mejdani M; Trost CN; Hicks BT; Lee J; Sontheimer EJ
    Annu Rev Biochem; 2020 Jun; 89():309-332. PubMed ID: 32186918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.